Jan 08, 2013, 05.18 PM | Source: Moneycontrol.com
Angel Broking has maintained a neutral rating on Marico. As per the research firm, the demerger of the loss making venture would result in Marico turning into a pure FMCG play enjoying superior return ratios.
, Angel Broking |
"The Board of Directors of Marico has approved the restructuring of businesses, corporate entities and the organization involving a) the demerger of Kaya Skin Care Solutions (Kaya) into a separate company by the name Marico Kaya Enterprises Ltd (MaKE) and b) formation of an unified FMCG business with operations in India and abroad, headed by a single CEO. The restructuring plan would be effective from April 1, 2013.
Kaya to be demerged into a separate listed company: As per the proposed demerger plan for Kaya, MaKE will become the holding company of Kaya Ltd (India) and Kaya entities in the Middle East and South East. Currently the promoters of Marico have a 60% stake in the company (Marico); post demerger the shareholding structure of MaKE will be identical to Marico’s current shareholding structure. Shareholders of Marico will be allotted one share of MaKE for every 50 shares held in Marico. Marico will not hold any stake in MaKe post demerger. The equity shares of MaKE will be listed after all the statutory approvals are obtained.
Formation of a unified FMCG business: Marico currently has three business verticals namely a) Indian consumer products b) the international FMCG business and c) Kaya with operations in India and abroad. Post the restructuring, Kaya would operate as a separate listed entity (MaKE). The Indian and International FMCG businesses, which were till date headed by two different CEOs, will be unified and headed by a single CEO.
Outlook and Valuation: Kaya has been a loss making venture for Marico and during FY2012 Kaya made a loss of Rs 29cr at the PBIT level on net sales of Rs 279cr (a loss of Rs 33cr in FY2011). The demerger of the loss making venture would result in Marico turning into a pure FMCG play enjoying superior return ratios. At the current market price, Marico is fairly priced, trading at 28x FY2014E earnings. We maintain a Neutral on Marico," says Angel Broking research report.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click here
Sensex 22K risk on; 3 factors key for bottom: Ambit Cap
With the Sensex breaking below 23,000, Saurabh Muk
Expect Marico to test Rs 260, says Shubham Agarwal
Shubham Agarwal of Motilal Oswal Securities expect
Buy Marico; target of Rs 260:Religare
Religare is bullish on Marico and has recommended
Metro Cash & Carry India appoints Arvind Mediratta as new MD
Arvind Mediratta takes over from Rajeev Bakshi, wh
Q3 volume growth due to several proactive initiatives: Marico
According to Saugata Gupta, MD & CEO, Marico raw m
Marico Q3 net up 23.71% to Rs 197.8 crore
The company had posted a net profit of Rs 159.88 c
Subscribe with caution to Quick Heal IPO: Choice Broking
Choice Broking has come out with its report on Qui
Marico great bet at lower levels: Mehraboon Irani
Mehraboon Irani of Nirmal Bang Securities is of th